Twenty-five hydroxycholecalciferol as a cholecalciferol substitute in broiler breeder hen diets and its effect on the performance and general health of the progeny

The effects of 1a(OH)D3 individually or in combination with phytase, and different levels of cholecalciferol on performance, tibia criteria, and plasma minerals of Japanese quails

The aim of studywas to compare efficacy of 1-α(OH)D3 alone or in combination with phytase and 1-α(OH)D3 in combination of phytase and different concentration of cholecalciferol on performance, tibia parameters, andplasma minerals of quails fed Ca-P deficient diet. A total of 280 mixed sex 5-d-old quails were allocated to 7 treatments with 5 replicates. The vitamin supplement which incorporated to basal diet did not contain cholecalciferol. The dietary treatments were as follows: Ca-P deficient diet (basal diet); basal diet + 500 FTU phytase/kg of diet; basal diet + phytase + 5 μg of 1-α(OH)D3 kg-1 of diet;basal diet + phytase + 5 μg of 1-α(OH)D3 and 250, 500, 750 and 1,000 IU of cholecalciferol kg-1of diet. The highest final body weight and the best feed conversion ratioobtained in the group supplemented with 1,000 IU cholecalciferol kg-1 of diet (p < 0.05). Supplementation of 1-α(OH)D3 alone or in combination with phytase and phytase and different concentration of cholecalciferol could improve tibia parameters (p < 0.05). In conclusion, supplementation of 1-α(OH)D3 alone to Ca-P deficient diet could maximize tibia mineralization, whereas it couldn't maximize performance, performance criteria were maximized by supplementation of 1,000 IU cholecalciferol kg-1 of diet.

Role of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 in Chicken Embryo Osteogenesis, Adipogenesis, Myogenesis, and Vitamin D3 Metabolism

A study was conducted to understand the effects of 25-hydroxyvitamin D₃ (25OHD) and 1,25-dihydroxyvitamin D₃ (1,25OHD) administration on the expression of key genes related to osteogenesis, adipogenesis, myogenesis, and vitamin D₃ metabolism in the chicken embryo. A total of 120 fertilized Cobb 500 eggs were used in the current study and were reared under standard incubation conditions. On embryonic day 3 (ED 3), PBS (C), PBS with 40ng 1,25OHD (1,25D-L), 200ng 1,25OHD (1,25D-H), 40ng 25OHD (25D-L), or 200ng 25OHD (25D-H) were injected into the dorsal vein of developing embryos. Whole embryos were harvested at 1, 3, and 6h post-injection for gene expression analyses (n=8). Gene expression for key osteogenesis markers (RUNX2: runt-related transcription factor 2; BMP2: bone morphogenetic protein 2; COL1A2: collagen type I alpha 2 chain; BGLAP: bone gamma-carboxyglutamate protein; SPP1: secreted phosphoprotein 1; and ALP: alkaline phosphatese), adipogenesis markers (PPAR-γ: peroxisome proliferator-activated receptor gamma; FASN: fatty acid synthase; and FABP4: fatty acid binding protein 4), myogenesis markers (MYOG: myogenin; MYOD1: myogenic differentiation 1; and MYF5: myogenic factor 5), and the enzyme responsible for vitamin D₃ inactivation (CYP24A1: cytochrome P450 family 24 subfamily A member 1) were measured using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Data were normalized by the ΔΔCT method and analyzed using a one-way ANOVA. Results indicated that at 1h post-injection, no differences were found among treatments. At 3h, the early osteogenesis differentiation marker, ALP, was increased by 1,25D-H and 25D-H, and 25D-H also stimulated the expression of adipogenesis markers (FAPB4 and FASN). In contrast, the expression of myogenesis markers (MYOD1 and MYF5) was suppressed by 25OHD or 1,25OHD treatments, respectively. At 6h, a late osteogenic differentiation marker, SPP1, was increased by 25D-H. MYOD1 and MYF5 were continuously suppressed by 25OHD treatments or 1,25D-H. The evidence of vitamin D₃ metabolite retention was assessed by measuring CYP24A1 expression. At 1h, there were no differences in CYP24A1 expression. At 3h, all treatments upregulated CYP24A1 expression relative to control (PBS) embryos. However, at 6h, only the 25D-H group retained higher CYP24A1 expression compared to the other treatments. In conclusion, the results suggested both 1,25OHD and 25OHD induced chicken embryo osteogenesis and adipogenesis, but inhibited myogenesis during early chicken embryo development. The higher dosage of 25OHD showed a possibility of a longer retention time in the embryos.

Investigation of different levels of cholecalciferol and its metabolite in calcium and phosphorus deficient diets on growth performance, tibia bone ash and development of tibial dyschondroplasia in broilers

This experiment was conducted to examine the effects of 1-α(OH)D3 alone or in combination with different levels of cholecalciferol on performance, and tibia parameters of one-d–old male broilers fed a tibial dyschondroplasia (TD)-inducing diet. A total of three hundred male broilers were randomly allocated to 5 treatment groups with 4 replicates. The dietary treatments consisted of TD inducing diet, TD inducing diet supplemented with 5 μg per kg of 1-α(OH)D3; TD inducing diet supplemented with 5 μg per kg of 1-α(OH)D3 and 1,500; 3,000 or 5,000 IU cholecalciferol kg-1 of diet. At 42 d of age, broiler chickens fed diets containing 1-α(OH)D3 and 1,500 IU cholecalciferol kg-1 of diet had higher body weight (p < 0.05). In the complete experimental period the best FCR and the highest daily weight gain were obtained in broilers supplemented with 1-α(OH)D3 and 1,500 IU cholecalciferol kg-1 of diet. Broilers supplemented with 1-α(OH)D3 and 1,500 IU cholecalciferol kg-1 of diet had significantly lower incidence and severity of TD in comparison with other groups. In conclusion, the results indicated that the supplementation of 1-α(OH)D3 in combination of 1,500 IU cholecalciferol kg-1 of diet could maximize tibia bone ash, performance and prevent TD in broilers fed TD inducing diet.

Effects of additional dosage of vitamin D3, vitamin D2, and 25-hydroxyvitamin D3 on calcium and phosphorus utilization, egg quality and bone mineralization in laying hens

Vitamin D is essential for the metabolism of calcium (Ca) and phosphorus (P) in birds. The objective of the study was to evaluate the effect of different isoforms of dietary vitamin D on Ca and P utilization, egg quality, and bone mineralization of laying hens. A total of 42 Lohmann white laying hens at 57 wk of age were randomly assigned to 7 dietary treatments for 6 wk. Dietary treatments were: 3,000 IU/kg Vit D₃ as control, and control with additional 3,000 IU/kg 25-hydroxyvitamin D₃ (T1), 9,000 IU/kg 25-hydroxyvitamin D₃ (T2), 3,000 IU/kg vitamin D3 (T3), 9,000 IU/kg vitamin D₃ (T4), 3,000 IU/kg of vitamin D₂ (T5), or 9,000 IU/kg of vitamin D₂ (T6). Egg production and egg quality were measured weekly. Fecal samples were collected at weeks 2 and 6 to measure Ca and P utilization. After 6 wk, the left tibia and femurs were collected to measure bone mineral density (BMD) and bone mineral content (BMC). A 1-way ANOVA with Tukey HSD means separation test was used for statistical analysis. There were no significant differences in egg production, egg quality, BMD, or BMC of tibia and femurs among the treatments (P > 0.05). T6 significantly reduced feed intake (P < 0.05). The apparent total tract digestibility (ATTD) of Ca was higher (P < 0.012) in treatments supplemented with additional vitamin D, irrespective of forms. The ATTD of P was higher (P < 0.0001) in T5 compared to the other treatments at both time points. The utilization of Ca and P by laying hens can be improved through the addition of different isoforms of vitamin D in diets. However, additional vitamin D supplementation to laying hens, regardless of forms, had no effect on either bone mineralization or measures of egg quality.

High vitamin levels ameliorate negative effect of rapeseed meal in meat ducks by improving antioxidant activity

The purpose of this study was to test the hypothesis that a high level of a vitamin premix would prevent the deleterious effects of rapeseed meal (RSM) when added to the diet of Pekin meat ducks. A total of 674 fifteen-day-old ducks were randomly allocated to 6 treatments with 7 cages of 16 ducks each. Three diets were formulated that contained 5, 10, or 20% RSM to compensate for reducing levels of soybean meal. Each RSM level diet was then supplemented with either a low level (low) or a high level (high) of a vitamin premix providing a total of 6 experimental diets. Ducks were fed one of the 6 experimental diets (N = 7 pens per diet) from days 15 to 35 at which time they were euthanized. Ducks were analyzed for antioxidant activity, liver biochemistry, thyroid hormone levels, and liver and thyroid histopathology. Addition of the high vitamin premixes to the 5 or 10% RSM diets improved BW (P < 0.05), BW gain (BWG; P < 0.05), and feed to gain ratio (F/G; P < 0.05) compared to the low vitamin premix; however, neither vitamin premix level had effects on production variables of ducks fed the 20% RSM diet. The high vitamin premix level also improved antioxidant capacity as evidenced by increased (P < 0.05) serum and liver superoxide dismutase activities over that of the low vitamin premix diets. Furthermore, the high level of vitamin premix prevented liver and thyroid pathologies in diets that contain RSM compared to diets with the low vitamin premix. These results suggested that high vitamin premix could prevent the negative effects of a 5 or 10% RSM diet in ducks by improving antioxidative capacities and alleviating liver and thyroid damage.

The effects of in ovo injected vitamin D3 sources on the eggshell temperature and early posthatch performance of Ross 708 broilers,. Poult Sci 2019;99:1357-1362. [PMID: 32115025 PMCID: PMC7587651 DOI: 10.1016/j.psj.2019.10.055]

The effects of in ovo injected vitamin D₃ source on eggshell temperature (ET) and performance of broilers through 14 D of age (doa) were investigated. Eggs from a 35-wk-old commercial Ross 708 broiler breeder flock were set in a single-stage incubator with 4 treatments representing each of 12 incubator tray levels (blocks). At 432 h of incubation (hoi), noninjected and diluent-injected (50 μL) groups were control treatment groups. Vitamin treatments in the commercial diluent were as follows: 2.4 μg of vitamin D₃ (D₃) or 25-hydroxylcholecalciferol (25OHD₃). After injection, ET readings were recorded (435, 441, 453, 459, and 465 hoi) by infrared thermometry. Hatchability, hatchling BW, and percentage of male and female hatchlings were determined at 502 hoi. Equal numbers of male and female chicks were placed in each pen and grown out for 14 doa. On a per-pen basis, BW was recorded after hatching at day 7 and 14 doa, and BW gain, average daily BW gain, feed intake (FI), and feed conversion ratio (FCR) were calculated between 0 to 14 doa. The ET of eggs significantly fluctuated during the postinjection time period; however, the type of vitamin D₃ source injected did not affect ET. Nevertheless, the injection of 25OHD₃ resulted in a lower late embryo mortality than the diluent and D₃ injection treatments. In addition, birds that received 25OHD₃ had a lower FI and FCR than birds in all other treatments. In conclusion, the in ovo injection of 25OHD₃ has the potential to improve early posthatch broiler performance without affecting ET.

Effects of calcium, phosphorus, and vitamin D on growing mink (Mustela vison)

The present study investigated the effects of dietary calcium (Ca), phosphorus (P), and vitamin D (VD) supplements on growth performance, Ca:P digestion and metabolism, and serum biochemical indexes of growing male mink (Mustela vison) under conditions of a fixed 2:1 ratio of Ca to P. About 135 dark male mink were randomly assigned to nine groups. The experiment was conducted with a 3 × 3 (Ca:P × VD) factorial design using a corn–fish meal-based diet that contained 2.3% Ca, 1.15% P, and 2100 IU kg−1 VD. The supplementary Ca and P levels were 0%:0%, 0.4%:0.2%, and 0.8%:0.4% of the diets, respectively, whereas supplementary VD levels were 0, 2000, and 4000 IU kg−1. The Ca and P dosage had a significant effect on growth performance of the mink (P < 0.05). The appropriate VD level, which was 4100 IU kg−1, significantly improved protein utilization and Ca and P digestibility of growing mink (P < 0.05). In addition, excreta pollution to the environment was also significantly reduced (P < 0.05). In conclusion, Ca:P (3.1%:1.55%) and VD (4100 IU kg−1) had an important effect on growth performance and protein utilization in growing mink and could reduce environmental pollution by improving protein and P utilization.

Vaccine to fibroblast growth factor 23 peptides increases eggshell strength

Strategies that would increase eggshell quality could be of considerable value to egg producers. This research demonstrated the effective use of fibroblast growth factor 23 (FGF-23) peptide vaccines to increase eggshell quality of Single Comb White Leghorn laying hens (from 69 to 72 wk of age). Hens, fed a standard diet (containing 900 IU/kg vitamin D3), were intramuscularly injected (and boosted) with either a control vaccine (n = 14 hens) or one of 2 FGF-23 peptide vaccines (peptides NP1, GMNPPPYS; and NP7, YTSTERNSFH; n = 15 hens for each peptide). During peak antibody titer, eggs were collected for shell and internal quality analysis, hens were artificially inseminated, and the hatchability of fertilized eggs was determined. Laying hens vaccinated with either FGF-23 peptide NP1 or NP7 had increased (P < 0.05) plasma phosphate level (mmol/L; NP1 = 1.74, NP7 = 1.76, control = 1.47), egg specific gravity (NP1 = 1.083, NP7 = 1.083, control = 1.079), and eggshell strength (g of force; NP1 = 4002, NP7 = 4157, control = 3102) when compared to control vaccinated hens. FGF-23 peptide NP1 vaccinated hens also had increased eggshell thickness (mm, P < 0.001), shell weight (g, P = 0.032), and shell index (% of whole egg, P = 0.023) when compared to control vaccinated hens. FGF-23 peptide NP7 vaccinated hens tended to have decreased eggshell weight (P = 0.064) when compared to control vaccinated hens. Hatchability of fertilized eggs was not affected in incubations 1 and 3, but tended to be decreased (P = 0.097) by FGF-23 peptide NP1 vaccination in incubation 2. In conclusion, vaccines to FGF-23 peptides increased eggshell quality of laying hens with minimal adverse effects on egg internal quality. The effect of FGF-23 peptide vaccination on hatchability remains to be clarified.

UV-light and dietary vitamin D and their effects on ionized calcium and 25-OH-D plasma concentrations in captive gentoo penguins (Pygoscelis papua)

In this study, the effect of ultraviolet (UV) light and dietary vitamin D on calcium metabolism in permanently indoor-housed gentoo penguins (Pygoscelis papua) was investigated. The study consisted of three periods, each completed with blood samples to analyse plasma concentrations of 25-OH-D, 1,25-(OH)₂ -D, ionized (iCa) and total calcium (tCa). During the first study period (D), animals were housed under routine conditions without UV-light and fed a diet of different fish species, supplemented with 1,000 IU vitamin D per animal and day. The following study period (Baseline) of 28-day duration consisted of the same diet without any vitamin D supplementation and without UV-light. During the study period (UVB) artificial UV-light was added for 3 weeks. The vitamin D content of fish was measured by high-performance liquid chromatography. It varied between fish species and between facilities, ranging from no measurable content in capelin (Mallotus villosus) to 7,340 IU vitamin D/kg original matter (OM) in herring (Clupea spp). The average dietary vitamin D content was 311 IU/kg OM at facility 1 and 6,325 IU/kg OM at facility 2, resulting in a vitamin D intake per animal and day without supplementation of 130 IU (25.5 IU/kg body weight BW) and 2,454 IU (438.2 IU/kg BW) respectively. The supplementation of vitamin D elevated significantly the plasma concentrations of 25-OH-D by an intraindividual difference of 15 (range -2 to 59) nmol/L and tCa by 0.1 (0.0-0.3) mmol/L only at facility 2. The exposure to UV-light raised the blood concentrations of tCa at facility 2 by 0.15 (0.1-0.2) mmol/L, and of iCa and tCa for females at facility 1 by 0.23 (0.13-0.41) mmol/L and 1.8 (1.1-2.5) mmol/L respectively. No significant influence of the study periods (D) and (UVB) was found for the concentrations of 1,25-(OH)₂ -D at both facilities.

Effects of dietary 1 alpha-hydroxycholecalciferol in calcium and phosphorous-deficient diets on growth performance, tibia related indices and immune responses in broiler chickens

This experiment was conducted to investigate the effect of dietary 1α-hydroxycholecalciferol (1α-OH-D₃) in calcium (Ca)- and phosphorous (P)-deficient diets on growth performance, carcass characteristics, tibia related parameters, and immune responses of broiler chickens. A total of 280 one-day-old broiler chickens (Ross 308) were assigned to 20 floor pens and 4 dietary treatments with 5 replicates. Dietary treatments consisted of starter diets (starter diet of treatment A: 1% Ca, 0.73% total phosphorus [tP]; starter diet of treatment B: 0.85% Ca, 0.64% tP + 5 μg/kg of 1α-OH-D₃; starter diet of treatment C: 0.85% Ca, 0.59% tP + 5 μg/kg of 1α-OH-D₃; starter diet of treatment D: 0.85% Ca, 0.54% tP + 5 μg/kg of 1α-OH-D₃), grower diets (grower diet of treatment A: 0.86% Ca, 0.68% tP; grower diet of treatment B: 0.73% Ca, 0.59% tP + 5 μg/kg of 1α-OH-D₃; grower diet of treatment C: 0.73% Ca, 0.55% tP + 5 μg/kg of 1α-OH-D₃; grower diet of treatment D: 0.73% Ca, 0.50% tP + 5 μg/kg of 1α-OH-D₃) and finisher diets (finisher diet of treatment A: 0.81% Ca, 0.64% tP; finisher diet of treatment B: 0.68% Ca, 0.56% tP + 5 μg/kg of 1α-OH-D₃; finisher diet of treatment C: 0.68% Ca, 0.52% tP + 5 μg/kg of 1α-OH-D₃; finisher diet of treatment D: 0.68% Ca, 0.48% tP + 5 μg/kg of 1α-OH-D₃). Results showed that body weight gain (BWG) and feed intake (FI) of broilers in treatment B were similar to those of broilers in treatment A at the end of the trial (P < 0.05). Broilers in treatments C and D had lower BWG and FI than those in treatment A during the whole trial (P < 0.05). Feed conversion ratio, carcass traits and relative weight of lymphoid organs were not affected by dietary treatments (P > 0.05). Dietary treatments had no significant effect on antibody titers against Newcastle and Influenza disease viruses as well as sheep red blood cells. Dietary treatments had no significant effects on tibia ash and tibial dyschondroplasia score. Broilers fed Ca-P deficient diets had lower tibia Ca and P than those in treatment A (P < 0.05). In conclusion, results indicated that broilers fed Ca-P deficient diets supplemented with 5 μg/kg 1α-OH-D₃ failed to achieve the same tibia Ca and P values as broilers fed nonphytate phosphorus adequate diets.

Relative biological value of 1α-hydroxycholecalciferol to 25-hydroxycholecalciferol in broiler chicken diets

This study was conducted to evaluate the relative biological value (RBV) of 1α-hydroxycholecalciferol (1α-OH-D3) to 25-hydroxycholecalciferol (25-OH-D3) in one- to 21-day-old broiler chickens fed calcium (Ca)- and phosphorus (P)-deficient diets. On the d of hatch, 450 male Ross 308 broiler chickens were weighed and randomly allotted to 9 treatments with 5 replicates of 10 birds per replicate. The basal diet contained 0.50% Ca and 0.25% non-phytate phosphorus (NPP) but was not supplemented with cholecalciferol (vitamin D3). The levels of Ca and NPP in basal diets were lower than those recommended by NRC (1994). 25-OH-D3 was fed at zero, 1.25, 2.5, 5.0, and 10.0 μg/kg, and 1α-OH-D3 was fed at 0.625, 1.25, 2.5, and 5.0 μg/kg. The RBV of 1α-OH-D3 to 25-OH-D3 based on vitamin D intake was determined by the slope ratio method. Results showed that 25-OH-D3 or 1α-OH-D3 improved the growth performance and decreased the mortality in one- to 21-day-old broilers. A linear relationship was observed between the level of 25-OH-D3 or 1α-OH-D3 and mineralization of the femur, tibia, or metatarsus. The RBV of 1α-OH-D3 to 25-OH-D3 were 234, 253, and 202% when the weight, ash weight, and Ca percentage of femur were used as criteria. The corresponding RBV of 1α-OH-D3 to 25-OH-D3 were 232 to 263% and 245 to 267%, respectively, when tibia and metatarsus mineralization were used as criteria. These data indicate that when directly feeding a hormonally active form of vitamin D as 1α-OH-D3 proportionally less is needed than when using the precursor (25-OH-D3) in diets deficient in Ca and P.

Effects of Maternal and Progeny Dietary Vitamin Regimens on the Performance of Ducklings

This study evaluated the interaction effect of maternal and progeny vitamin regimens on the performance of ducklings. At 38 weeks of age, 780 female and 156 male duck breeders were fed either regular or high vitamin premix diet (maternal high premix had higher levels of all vitamins except K₃ than maternal regular premix) for 16 weeks. Ducklings hatched from eggs laid at the end of the duck breeder trial were kept separate according to maternal treatment and were fed 2 levels of vitamin premix (NRC and high, progeny high premix had higher levels of all vitamins except biotin than progeny NRC premix) for 35 days. Body weight (P<0.001) and tibia ash (P=0.033) of 1-day-old ducklings and serum total superoxide dismutase activity of 14-day-old ducklings (P=0.027) were increased by maternal high vitamin premix. Progeny high vitamin premix increased body weight (14 days, P=0.019; 35 days, P=0.034), body weight gain (1–14 days, P=0.021; 1–35 days, P=0.034), gain:feed ratio (1–14 days, P<0.001), feed intake (15–35 days, P=0.037), serum total antioxidant capacity (14 days, P=0.048; 35 days, P=0.047), and serum calcium (14 days, P=0.007), and decreased serum malondialdehyde (14 days, P=0.038; 35 days, P=0.031) of ducklings. Maternal vitamin premix–progeny vitamin premix interaction significantly affected body weight (14 days, P=0.029), body weight gain (1–14 days, P=0.029), and feed intake (1–14 days, P=0.018) of progeny ducklings. Briefly, progeny NRC premix decreased the growth performance (days 1–14) of ducklings from maternal regular vitamin group, but not duckling from maternal high vitamin group. The results demonstrate a shortcoming of current vitamin recommendations for ducklings and suggest that the vitamin needs of starter ducklings can be met by either maternal or progeny vitamin supplementation.

Evaluation of one-alpha-hydroxy-cholecalciferol alone or in combination with cholecalciferol in Ca-P deficiency diets on development of tibial dyschondroplasia in broiler chickens

This experiment was conducted to determine whether dietary cholecalciferol will alleviate a calcium and phosphorous (Ca—P) deficiency when one-alpha-hydroxy-cholecalciferol, 1α(OH)D₃, is supplemented, and to determine the effects of adequate and inadequate Ca—P when 1α(OH)D₃ is supplemented and vitamin D₃ is adequate. A total of 144 one-d-old broiler chicks (Ross 308) were allocated to 3 treatments. The dietary treatments were as follows: treatment A, adequate Ca—P + cholecalciferol + 5 μg/kg 1α(OH)D₃; treatment B, inadequate Ca—P + cholecalciferol + 5 μg/kg 1α(OH)D₃; treatment C, inadequate Ca—P + 5 μg/kg 1α(OH)D₃. All diets were mixed with 500 FTU/kg of phytase, and cholecalciferol was provided in 5,000 IU/kg except for treatment C that fed diets without vitamin D_3. The Ca—P levels in the adequate diets were 0.90% Ca, 0.66% total phosphorus (tP); 0.75% Ca, 0.59% tP; 0.69% Ca, 0.54% tP for the starter, grower and finisher periods. At d 42 of age, broilers were inspected for incidence and severity of tibial dyschondroplasia (TD). The results showed that inadequate Ca—P supplementation with cholecalciferol significantly decreased the incidence of TD, score and tibia ash compared with broilers fed the same diet in the absence of cholecalciferol (P < 0.05). The broilers fed inadequate Ca—P diets with cholecalciferol were unable to achieve the same tibia ash and incidence of TD as those fed Ca—P adequate diets (P < 0.05). In conclusion, this trial suggests that broilers fed an inadequate Ca—P diet with 1α(OH)D₃ and adequate level of cholecalciferol are unable to sufficient bone formation. There was no indication that 1α(OH)D₃ in the absence of cholecalciferol was effective in reducing TD whereas it could improve tibia ash.

Effect of maternal canthaxanthin and 25-hydroxycholecalciferol supplementation on the performance of ducklings under two different vitamin regimens

This study investigated the effects of maternal canthaxanthin (CX, 6 mg/kg) and 25-hydroxycholecalciferol (25-OH-D₃ , 0.069 mg/kg) supplementation on the performance of Cherry Valley ducklings under two different vitamin regimens. A total of 780 duck breeder females and 156 males were randomly allotted to two diets with or without the addition of the mixture of CX and 25-OH-D₃ (CX+25-OH-D₃ ) for 32 weeks. Ducklings (males and females separately) hatched from eggs laid at 24 weeks of the duck breeder trial were fed with a NRC vitamin regimen, and ducklings (males and females separately) hatched from eggs laid at 32 weeks of the duck breeder trial were fed with a HIGH vitamin regimen (had higher levels of all vitamins except biotin than NRC vitamin regimen), for 14 days. The results showed that, maternal CX+25-OH-D₃ supplementation increased the shank pigmentation for 7-days post hatch in ducklings under a NRC vitamin regimen, and for 14-days post hatch in ducklings under a HIGH vitamin regimen. Growth performance, antioxidant status and serum phosphorus of ducklings under a NRC vitamin regimen were increased by maternal CX+25-OH-D₃ supplementation; however, these positive effects were not observed in ducklings under a HIGH vitamin regimen. Males revealed increased growth performance in ducklings under both NRC and HIGH vitamin regimens. Sexual differences in shank pigmentation, antioxidant status, tibia strength and serum phosphorus were not consistent as they were dependent on maternal CX+25-OH-D₃ status or dietary vitamin regimens. Data suggest that maternal CX+25-OH-D₃ supplementation is important for starter ducklings under a NRC vitamin regimen, but not HIGH vitamin regimen.

Effects of dietary canthaxanthin and 25-hydroxycholecalciferol supplementation on the antioxidant status and tibia quality of duck breeders and newly hatched ducklings

This study evaluated the effects of dietary canthaxanthin (CX) and 25-hydroxycholecalciferol (25-OH-D3) supplementation on the antioxidant status and tibia quality of duck breeders and newly hatched ducklings. In total, 780 female and 156 male duck breeders were randomly allotted to 2 treatments. Duck breeders were fed either a commercial diet (containing 3,000 IU/kg vitamin D3) or the same diet plus a mixture of CX (6 mg/kg) and 25-OH-D3 (0.069 mg/kg) for 40 wk. The antioxidant status of duck breeders, egg yolk, and ducklings; tibia quality of duck breeders and ducklings; and shell quality of breeder eggs were investigated. The total antioxidant capacity of breeder female liver (P = 0.028), breeder male testis (P = 0.049), egg yolk (P = 0.032), one-day-old duckling liver (P = 0.024), and one-day-old duckling yolk sac (P = 0.012) were increased by dietary supplementation of the mixture of CX and 25-OH-D3 The inclusion of CX and 25-OH-D3 decreased liver protein carbonyl of breeder females (P = 0.030), and liver malonaldehyde (P = 0.050) and protein carbonyl (P = 0.030) of breeder males. Yolk (P < 0.001), shank (P < 0.001), and yolk sac pigmentation (P < 0.001) of one-day-old ducklings were increased by the supplementation of the CX and 25-OH-D3 mixture. No differences (P > 0.05) were observed in tibia quality or eggshell quality between treatments. In conclusion, the inclusion of the mixture of CX and 25-OH-D3 in a diet sufficient in vitamin D3 increased antioxidant status but not tibia quality of duck breeders and newly hatched ducklings.

In ovo feeding with minerals and vitamin D3 improves bone properties in hatchlings and mature broilers

The objective of this study was to examine the effect of in ovo feeding (IOF) with inorganic minerals or organic minerals and vitamin D3 on bone properties and mineral consumption. Eggs were incubated and divided into 4 groups: IOF with organic minerals, phosphate, and vitamin D3 (IOF-OMD); IOF with inorganic minerals and phosphate (IOF-IM); sham; and non-treated controls (NTC). IOF was performed on embryonic day (E) 17; tibiae and yolk samples were taken on E19 and E21. Post-hatch, only chicks from the IOF-OMD, sham, and NTC were raised, and tibiae were taken on d 10 and 38. Yolk mineral content was examined by inductively coupled plasma spectroscopy. Tibiae were tested for their whole-bone mechanical properties, and mid-diaphysis bone sections were indented in a micro-indenter to determine bone material stiffness (Young's modulus). Micro-computed tomography (μCT) was used to examine cortical and trabecular bone structure. Ash content analysis was used to examine bone mineralization. A latency-to-lie (LTL) test was used to measure standing ability of the d 38 broilers. The results showed that embryos from both IOF-OMD and IOF-IM treatments had elevated Cu, Mn, and Zn amounts in the yolk on E19 and E21 and consumed more of these minerals (between E19 and E21) in comparison to the sham and NTC. On E21, these hatchlings had higher whole-bone stiffness in comparison to the NTC. On d 38, the IOF-OMD had higher ash content, elevated whole-bone stiffness, and elevated Young's modulus (in males) in comparison to the sham and NTC; however, no differences in standing ability were found. Very few structural differences were seen during the whole experiment. This study demonstrates that mineral supplementation by in ovo feeding is sufficient to induce higher mineral consumption from the yolk, regardless of its chemical form or the presence of vitamin D3. Additionally, IOF with organic minerals and vitamin D3 can increase bone ash content, as well as stiffness of the whole bone and bone material in the mature broiler, but does not lead to longer LTL.

Effect of dietary canthaxanthin and 25-hydroxycholecalciferol supplementation on the performance of duck breeders under two different vitamin regimens

BACKGROUND

Dietary canthaxanthin (CX), 25-hydroxycholecalciferol (25-OH-D 3 ) and vitamins have been widely reported to be involved in productive and reproductive performance of broiler breeders. However, limited information is available for duck breeders. In this study, a total of 1,560 Cherry Valley SM3 duck breeder females and 312 males were used to assess if the addition of CX and 25-OH-D3 could increase the performance of duck breeders under two different dietary vitamin regimens. Four diets were used under a 2 × 2 factorial arrangement with 2 kinds of vitamin premixes (REGULAR and HIGH; HIGH premix had higher levels of all vitamins except K3 than REGULAR premix), and with or without the supplementation of the mixture of CX (6 mg/kg) and 25-OH-D3 (0.069 mg/kg). The ducks were fed ad libitum with pelleted diets based on corn-soybean meal from 38 to 77 wk of age.

RESULTS

HIGH vitamin premix decreased malondialdehyde (MDA) level (P < 0.001) of egg yolk, increased hatchability of fertile eggs (P = 0.029), increased hatchability of total eggs (P = 0.029), and decreased serum protein carbonyl level (P = 0.037) of breeder males. The mixture of CX and 25-OH-D3 increased serum calcium of breeder females (P = 0.010), decreased the cracked egg rate (P = 0.001), increased the pigmentation of egg yolk (P < 0.001) and male bill (P < 0.001), and decreased MDA level of egg yolk (P < 0.001) and male serum (P = 0.034). Interactive effects were observed in cracked egg rate (P = 0.038), shell thickness (P = 0.011) and serum phosphorus (P = 0.026) of breeder females. HIGH vitamin premix together with the mixture of CX and 25-OH-D3 decreased cracked egg rate and increased shell thickness of duck breeders. Serum phosphorus was decreased in duck breeder females fed REGULAR vitamin premix without the addition of the CX and 25-OH-D3 mixture.

CONCLUSIONS

Dietary HIGH vitamin premix increased antioxidant status of eggs and breeder males, and increased hatchability. The mixture of CX and 25-OH-D3 enhanced egg shell quality, and promoted pigmentation and antioxidant status of eggs and breeder males.

The effects of maternal dietary vitamin premixes, canthaxanthin, and 25-hydroxycholecalciferol on the performance of progeny ducklings

This trial studied the effects of maternal dietary vitamin premixes, and the mixture of canthaxanthin (CX) and 25-hydroxycholecalciferol (25-OH-D3) on the performance of progeny ducklings. Four maternal diets were used under a 2 × 2 factorial arrangement with 2 kinds of vitamin premixes (Regular and High; High premix had higher levels of all vitamins except K3 than the Regular premix), and with or without the addition of the mixture of CX (6 mg/kg) and 25-OH-D3 (0.069 mg/kg). Cherry Valley duck breeders (38-wk-old) were fed with corn-wheat flour-soybean meal-based diets for 8 wk, and then eggs were collected and hatched. Healthy ducklings (equal number of female and male) from each maternal group were randomly selected and received the same commercial starter (1 to 14 d) and grower (15 to 35 d) pellet diet for 35 d. Maternal High vitamin premix increased shank pigmentation (1 d, P = 0.001), BW (1 d, P < 0.001 and 14 d, P = 0.006), BW gain (1 to 14 d, P = 0.008), G:F ratio (1 to 14 d, P = 0.007), superoxide dismutase (SOD; 1 d liver, P = 0.027 and 14 d serum, P = 0.031), and total antioxidant capacity (1 d liver, P < 0.001); and decreased protein carbonyl (14 d serum, P = 0.011) of ducklings. The mixture of CX and 25-OH-D3 increased yolk pigmentation (P < 0.001); increased shank pigmentation (1 d, P < 0.001 and 14 d, P < 0.001), BW (1 d, P < 0.001), feed intake (15-35 d, P = 0.014), SOD (1 d liver, P = 0.032), and tibia ash (14 d, P = 0.010) of ducklings; and decreased malondialdehyde (P < 0.001) and protein carbonyl (P = 0.044) of yolks, and malondialdehyde (14 d serum, P < 0.001) of ducklings. In conclusion, either maternal High vitamin premix or maternal supplementation of the CX and 25-OH-D3 mixture improves growth performance and antioxidant status of ducklings.

Can feeding the broiler breeder improve chick quality and offspring performance?

The impact of nutrition on the performance of broiler breeders in terms of bodyweight profile, egg production, egg size and shell quality, mortality, fertility and hatchability has been well documented. However, studies on the direct effects of breeder nutrition on subsequent chick quality and offspring performance are limited. The present paper reviews the nutritional factors in broiler breeders that may improve chick quality and progeny performance. Recent research has suggested that the feeding of low crude protein and medium to high energy breeder diets in both rearing and laying period will not only have a positive impact on egg production, egg size, breeder fertility, hatchability and embryonic livability, but also on offspring performance. Improvements include better chick quality, higher chick weight, lower mortality, increased immune responses, enhanced litter quality and broiler growth. Breast-meat yield in the progeny can be improved as the energy to protein ratio increases from the rearing phase to the laying phase, indicating that nutrition of pullets can also affect growth and yields. The effects of maternal diet on offspring performance may depend on the sex of the progeny, with male broilers responding more than female broilers to breeders’ dietary protein and energy concentrations. However, little work has been conducted on the effects of individual amino acids in breeder diets on the subsequent generation. There seems to be some benefits with the use of long-chain poly-unsaturated fats in breeder diets on carcass quality of offspring, but these effects appear inconsistent at this stage. There is substantial evidence that confirms the direct effects of vitamin D and E, and trace minerals, especially in organic form, such as selenium, zinc and manganese, on chick quality and progeny performance. In fact, the impact of breeder nutrition on progeny performance in the field is more likely to be greater under conditions of poor breeder-flock uniformity, low vitamin and trace mineral contents or certain types of stress in the broiler house.

Evaluation of Relative Bioavailability of 25-Hydroxycholecalciferol to Cholecalciferol for Broiler Chickens

This study was conducted to evaluate the relative bioavailability (RBV) of 25-hydroxycholecalciferol (25-OH-D₃) to cholecalciferol (vitamin D₃) in 1- to 21-d-old broiler chickens fed with calcium (Ca)- and phosphorus (P)-deficient diets. On the day of hatch, 450 female Ross 308 broiler chickens were assigned to nine treatments, with five replicates of ten birds each. The basal diet contained 0.50% Ca and 0.25% non-phytate phosphorus (NPP) and was not supplemented with vitamin D. Vitamin D₃ was fed at 0, 2.5, 5.0, 10.0, and 20.0 μg/kg, and 25-OH-D₃ was fed at 1.25, 2.5, 5.0, and 10.0 μg/kg. The RBV of 25-OH-D₃ was determined using vitamin D₃ as the standard source by the slope ratio method. Vitamin D₃ and 25-OH-D₃ intake was used as the independent variable for regression analysis. The linear relationships between the level of vitamin D₃ or 25-OH-D₃ and body weight gain (BWG) and the weight, length, ash weight, and the percentage of ash, Ca, and P in femur, tibia, and metatarsus of broiler chickens were observed. Using BWG as the criterion, the RBV value of 25-OH-D₃ to vitamin D₃ was 1.85. Using the mineralization of the femur, tibia, and metatarsus as criteria, the RBV of 25-OH-D₃ to vitamin D₃ ranged from 1.82 to 2.45, 1.86 to 2.52, and 1.65 to 2.05, respectively. These data indicate that 25-OH-D₃ is approximately 2.03 times as active as vitamin D₃ in promoting growth performance and bone mineralization in broiler chicken diets.

25-Hydroxycholecalciferol Enhances Male Broiler Breast Meat Yield through the mTOR Pathway

BACKGROUND

In recent years, there has been a growing body of evidence indicating that replacing cholecalciferol (vitamin D₃) with 25-hydroxycholecalciferol [25(OH)D₃] through dietary supplementation enhances breast meat yield in broiler chickens. However, the underlying molecular mechanisms are still unknown.

OBJECTIVE

We investigated the effect of 25(OH)D₃ on male broiler growth performance (body weight, feed intake, feed conversion ratio, and breast meat yield), muscle protein synthesis, and the potential underlying molecular mechanisms.

METHODS

Male Cobb 500 broiler chickens were divided into 4 body weight-matched groups and received a control diet with normal cholecalciferol (2760 IU/kg feed) for 42 d, a diet with high concentrations of cholecalciferol (5520 IU/kg feed) for 42 d, or a diet with 25(OH)D₃ (5520 IU/kg feed) for 42 d (HyD-42). A fourth group consumed the HyD-42 for 21 d and then control feed for 21 d (HyD-21) (n = 360 birds, 12 replicates/treatment). Food and clean water were available for ad libitum consumption. At the end of the 42-d experiment, protein turnover was measured by phenylalanine flooding dose. Breast muscle tissues were collected and protein synthesis-related gene and protein expression were measured by real time polymerase chain reaction and Western blot, respectively. Functional studies were performed in vitro with the use of a quail myoblast (QM7) cell line. QM7 cells were treated with 2 doses (1 nM and 10 nM) of cholecalciferol or 25(OH)D₃ alone or in combination with 100 nM rapamycin, and cell proliferation was determined by cell proliferation assay. Protein synthesis-related gene and protein expression were also determined.

RESULTS

The HyD-42 increased 25(OH)D₃ circulating concentrations by 126% (P < 0.05), enhanced breast meat yield (P < 0.05), and increased the fractional rate of protein synthesis by 3-fold (P < 0.05) compared with the control diet. Molecular analyses revealed that breast muscle from chickens consuming the HyD-42 expressed significantly higher concentrations of vitamin D receptor (VDR), phospho mechanistic target of rapamycin(Ser2481), phospho ribosomal P70 S6 kinase (RPS6K)(Thr421/Ser424), and antigen Ki-67 (Ki67) compared with the other groups. In line with the in vivo data, in vitro functional studies showed that cells treated with 25(OH)D₃ for 24 h had increased VDR expression, and activated the mechanistic target of rapamycin (mTOR)/S6 kinase (S6K) pathway, enhanced Ki67 protein concentrations, and induced QM7 cell proliferation compared with untreated or cholecalciferol-treated cells. Blocking the mTOR pathway with rapamycin reversed these effects.

CONCLUSION

Taken together, our findings provide evidence that the effects of 25(OH)D₃ on male broiler breast muscle are likely mediated through the mTOR-S6K pathway.

Triennial Growth Symposium--A role for vitamin D in skeletal muscle development and growth

Although well known for its role in bone development and mineral homeostasis, there is emerging evidence that vitamin D is capable of functioning as a regulator of skeletal muscle development and hypertrophic growth. This review will focus on the relatively limited body of evidence regarding the impact of vitamin D on prenatal development and postnatal growth of skeletal muscle in meat animal species. Recent evidence indicating that improvement of maternal vitamin D status through dietary 25-hydroxycholecalciferol supplementation can positively affect fetal skeletal muscle fiber number and myoblast activity in swine as well as work demonstrating that posthatch vitamin D status enhancement stimulates a satellite cell-mediated skeletal muscle hypertrophy response in broiler chickens is discussed. The relative lack of information regarding how and when to best supply dietary vitamin D to promote optimal prenatal development and postnatal growth of skeletal muscle provides an exciting field of research. Expansion of knowledge in this area will ultimately improve our ability to efficiently and effectively produce the livestock required to meet the increasing worldwide demand for meat products.

Effects of 25-hydroxycholecalciferol and soy isoflavones supplementation on bone mineralisation of quail

1. The effects of 25-hydroxycholecalciferol (25-OH-D(3)) and soy isoflavones supplementation on performance, carcase recovery, bone mineral density, and tibia ash, Ca, P, and serum vitamin D concentrations and alkaline phosphatase activity in the Japanese quail (Coturnix coturnix japonica) exposed to high ambient temperature were evaluated. 2. A total of 270 ten-d-old Japanese quail were randomly assigned to 9 treatment groups, 6 replicates of 5 birds each in a 2 x 3 x 3 factorial arrangement of treatments. Birds were kept in a temperature-controlled room at either 22 degrees C (thermo-neutral) or 34 degrees C (heat stress) for 8 h/d (09:00-17:00 h) and given a basal (control) diet or the basal diet supplemented with one of three levels of 25-OH-D(3) (0, 250 and 500 IU/kg of diet) combined with one of three levels of soy isoflavones (0, 400 and 800 mg/kg of diet). 3. Birds kept at 34 degrees C consumed less feed and gained less weight than control birds. An increase in body weight, feed intake (and improvement in feed efficiency and carcase recovery were found in soy isoflavones and 25-OH-D(3)-supplemented quail reared under heat stress conditions. Bone mineral density, tibia ash, Ca, and P were linearly improved by 25-OH-D(3) and soy isoflavones supplementation in both thermoneutral and heat stress groups. Serum vitamin D levels and alkaline phosphatase activity were improved by 25-OH-D(3) and soy isoflavones supplementation in both thermoneutral and heat stress groups in quail. 4. In conclusion, a combination of 25-OH-D(3) and soy isoflavones supplementation to basal diet significantly improved bone mineralisation in quail.